Literature DB >> 30829730

High-normal blood pressure and abnormal left ventricular geometric patterns: a meta-analysis.

Cesare Cuspidi1,2, Carla Sala3, Marijana Tadic4, Elisa Gherbesi3, Rita Facchetti1, Guido Grassi1,5, Giuseppe Mancia2.   

Abstract

AIM: The association between prehypertension (pre-HTN) and abnormal left ventricular (LV) geometric patterns is unclear. We performed a meta-analysis of echocardiographic studies aimed to provide a new piece of information on LV geometric alterations in untreated pre-HTN individuals.
DESIGN: Studies were identified by crossing the following search terms: 'prehypertension,' 'high normal blood pressure,' 'heart,' 'LV hypertrophy' (LVH), 'LV geometry,' 'LV mass,' and 'echocardiography.'
RESULTS: A total 60 949 participants (38 536 normotensive, 14 453 pre-HTN, and 7960 HTN individuals) were included in six studies. LV concentric remodelling was the most common abnormal pattern in pre-HTN participants followed by eccentric and concentric LVH. Compared with normotensive group, pre-HTN exhibited a higher risk of LV concentric remodelling (OR 1.89, CI 1.70-2.10, P < 0.001), eccentric LVH (OR 1.65, CI 1.40-1.90, P < 0.001) and concentric LVH (OR 2.09, CI 1.50-3.00, P < 0.001). The likelihood of having abnormal LV patterns in HTN was significantly higher (P < 0.001 for all) than in pre-HTN participants.
CONCLUSION: Our meta-analysis shows that alterations in LV geometry in pre-HTN individuals are intermediate between normotensive and HTN individuals. These findings suggest that pre-HTN is associated to early changes in LV structure and geometry, and preventive strategies may have a protective impact on development of subclinical cardiac damage in this setting.

Entities:  

Mesh:

Year:  2019        PMID: 30829730     DOI: 10.1097/HJH.0000000000002063

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  4 in total

1.  Association of Abnormal Serum L-Carnitine Levels with Idiopathic Changes in Left Ventricular Geometry in Pediatric and Adolescent Patients.

Authors:  Mohsen Shahidi; Khaled Rahmani; Abdorrahim Afkhamzadeh
Journal:  Iran J Med Sci       Date:  2022-05

Review 2.  Pharmacotherapy for hypertension-induced left ventricular hypertrophy.

Authors:  Leire Leache; Marta Gutiérrez-Valencia; Rosa M Finizola; Elizabeth Infante; Bartolome Finizola; Jordi Pardo Pardo; Yris Flores; Ricardo Granero; Kaduo J Arai
Journal:  Cochrane Database Syst Rev       Date:  2021-10-10

3.  Should blood pressure ≥130/80 mm Hg be considered as a cardiovascular disease?

Authors:  Marijana Tadic; Cesare Cuspidi
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-06-19       Impact factor: 3.738

4.  Blood Pressure Trajectories for 16 Years and the Development of Left Ventricular Hypertrophy and Increased Left Atrial Size: The Korean Genome and Epidemiology Study.

Authors:  Seong Hwan Kim; Ju-Mi Lee; Seung Ku Lee; Chol Shin; Jae-Hyeong Park
Journal:  Int J Hypertens       Date:  2022-07-18       Impact factor: 2.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.